Assisted reproduction and choice in the biotech age: recommendations for a way forward
By Francine Coeytaux, Marcy Darnovsky, Susan Berke Fogel,
Contraception
| 01. 01. 2011
[Editorial]
To view the PDF version of this article, please scroll down to the bottom of this page.
Over the past several decades, millions of people have used new reproductive technologies in their quest for biologically related children. Access to these technologies has enabled people who suffer from infertility, same-sex couples and single women to form biological families. At the same time, these tools can be used to select the sex of a future child [1] or to “de-select” based on a growing number of genetic markers for disabilities and other conditions [2]. While assisted reproductive technologies have increased parental options for those who can afford them, they pose numerous ethical challenges that the reproductive rights, health and justice communities are only beginning to address.
The assisted reproduction field has so far developed largely outside the realm of public policy and with little public discussion about how new technologies should be used and who should have access to them. Difficult questions have had minimal public airing. Should access to reproductive technologies be limited to those who can pay for them? Should...
Related Articles
By Daphne O. Martschenko and Julia E. H. Brown, Hastings Bioethics Forum | 01.14.2026
There is growing concern that falling fertility rates will lead to economic and demographic catastrophe. The social and political movement known as pronatalism looks to combat depopulation by encouraging people to have as many children as possible. But not just...
By Paula Siverino Bavio, BioNews | 01.12.2026
For more than ten years, gestational surrogacy in Uruguay existed in a state of legal latency: provided for by law, carefully regulated as an exception, yet without a single birth to make it real.
That situation changed with the arrival...
By Hannah Devlin, The Guardian | 01.08.2026
Scientists claim to have “rejuvenated” human eggs for the first time in an advance that they predict could revolutionise IVF success rates for older women.
The groundbreaking research suggests that an age-related defect that causes genetic errors in embryos could...
By Katherine Long, The Wall Street Journal | 12.27.2025
Nia Trent-Wilson owes $182,889.63 in medical bills for a baby that wasn’t hers.
In late 2021, she agreed to act as a surrogate through an agency that paired her with a gay couple from Washington, D.C. The terms were typical...